Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil

Open Vet J. 2021 Apr-Jun;11(2):217-221. doi: 10.5455/OVJ.2021.v11.i2.5. Epub 2021 Apr 25.

Abstract

Background: Lymphoma in the nasal cavity is the most common tumor of cats' upper respiratory tract. However, the effect of single-agent chlorambucil on nasal or nasopharyngeal lymphoma has not been evaluated in cats.

Case description: An 8-year-old, castrated male Scottish Fold weighing 3.5 kg presented with an 8-month history of nasal discharge, sneezing, and mild epistaxis. CT and rhinoscopy revealed nasal discharge and slight swelling of the nasopharyngeal mucosa, but no masses and local invasions were detected. Histopathological and immunohistochemical analyses of the nasopharyngeal mucosa demonstrated B-cell lymphoma in the cat. The treatment with chlorambucil led to long-term management of the cat without any side effects. No recurrences of clinical signs have been observed for 754 days.

Conclusion: The present case report suggests that chlorambucil can be a therapeutic option for feline localized nasopharyngeal B-cell lymphoma without masses and local invasions.

Keywords: Cat; Chlorambucil; Lymphoma; Nasal cavity; Nasopharynx.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Cats
  • Chlorambucil*
  • Lymphoma* / drug therapy
  • Lymphoma* / veterinary
  • Male
  • Nasal Cavity
  • Nasopharynx
  • Neoplasm Recurrence, Local

Substances

  • Chlorambucil